Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
586 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anticoagulants"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Oral anticoagulant treatment
2 Not yet recruiting Safety of Oral Anticoagulants Registry
Condition: Blood Coagulation
Intervention: Other: mgt of bleeding concerns/complications of oral anticoagulants
3 Recruiting Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
Condition: Atrial Fibrillation and Flutter
Intervention: Other: New oral anticoagulant pharmacodynamic analysis (blood level assesment)
4 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
5 Recruiting Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: novel oral anticoagulant for 30 days;   Drug: novel oral anticoagulant for 24 hour
6 Recruiting Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
Conditions: Ischemic Stroke;   Intracerebral Hemorrhage;   Oral Anticoagulation;   Cardiovascular Diseases;   Vascular Diseases
Intervention: Other: not applicable (observational study)
7 Recruiting A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG L-Asparaginase
Conditions: Lymphoma;   Acute Lymphoblastic Leukemia
Interventions: Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
8 Recruiting Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
Condition: Intra Operative Bleeding, Blood Salvage
Interventions: Drug: ACD-A;   Drug: Heparin
9 Not yet recruiting TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation
Conditions: Ischemic Stroke;   Atrial Fibrillation
Interventions: Other: Early start of NOAC;   Other: Late start of NOAC
10 Recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
11 Not yet recruiting COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Conditions: Stable Angina;   Unstable Angina;   STEMI;   NSTEMI;   Coronary Disease
Interventions: Device: COMBO-Stent;   Drug: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran;   Device: Any drug eluting stent oder bare metal sent;   Drug: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
12 Recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
13 Not yet recruiting Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants
Condition: Anticoagulants; Circulating, Hemorrhagic Disorder
Intervention: Drug: Activated Charcoal
14 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
Intervention:
15 Not yet recruiting Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation: A Study of Clinical Characteristics With Insight From Patient and Physician Perspectives
Condition: Nonvalvular Atrial Fibrillation
Intervention:
16 Recruiting Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Condition: Renal Insufficiency
Interventions: Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Heparin;   Drug: VKA
17 Not yet recruiting The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
Conditions: Chronic Kidney Disease;   Acute Bleeding;   Cerebrovascular Stroke
Interventions: Device: Watchman;   Drug: Continued therapy with the prescribed oral anticoagulant
18 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
19 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke;   Intracranial Hemorrhages
Intervention:
20 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.